Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2024 Aug 26.
Published in final edited form as: J Affect Disord. 2022 Feb 15;303:273–285. doi: 10.1016/j.jad.2022.02.031

Barriers to treatment for mental disorders in six countries of the Americas: A regional report from the World Mental Health Surveys

Ricardo Orozco 1,*, Daniel Vigo 2, Corina Benjet 1, Guilherme Borges 1, Sergio Aguilar-Gaxiola 3, Laura H Andrade 4, Alfredo Cia 5, Irving Hwang 6, Ronald C Kessler 6, Marina Piazza 7, José Posada-Villa 8, Claudia Rafful 9, Nancy Sampson 6, Juan Carlos Stagnaro 10, Yolanda Torres 11, María Carmen Viana 12, María-Elena Medina-Mora 1
PMCID: PMC11345908  NIHMSID: NIHMS2017483  PMID: 35176342

Abstract

Background:

Mental health treatment is scarce and little resources are invested in reducing the wide treatment gap that exists in the Americas. The regional barriers are unknown. We describe the barriers for not seeking treatment among those with mental and substance use disorders from six (four low- and middle-income and two high-income) countries from the Americas. Regional socio-demographic and clinical correlates are assessed.

Methods:

Respondents (n=4648) from seven World Mental Health surveys carried out in Argentina, Brazil, Colombia, Mexico, Peru, and the United States, who met diagnostic criteria for a 12-month mental disorder, measured with the Composite International Diagnostic Interview, and who did not access treatment, were asked about treatment need and, among those with need, structural and attitudinal barriers. Country-specific deviations from regional estimates were evaluated through logistic models.

Results:

In the Americas, 43% of those that did not access treatment did not perceive treatment need, while the rest reported structural and attitudinal barriers. Overall, 27% reported structural barriers, and 95% attitudinal barriers. The most frequent attitudinal barrier was to want to handle it on their own (69.4%). Being female and having higher severity of disorders were significant correlates of greater perceived structural and lower attitudinal barriers, with few country-specific variations.

Limitations:

Only six countries in the Americas are represented; the cross-sectional nature of the survey precludes any causal interpretation.

Conclusions:

Awareness of disorder or treatment need in various forms is one of the main barriers reported in the Americas and it specially affects persons with severe disorders.

Keywords: Latin America, Mental Disorders, Health Services Accessibility, Treatment Refusal

1. Introduction

Differences in accessing mental health treatment between high- and low-and-middle-income countries (LMICs) extends to all types of treatment and levels of care. In inpatient care, LMICs have 20 times less beds per unit and 30 times less admissions; in outpatient care there are 40 times less patients being treated, and 15 times less staff at the outpatient levels (Lora et al., 2020). In addition, there may be differences in treatment barriers. Recently, a qualitative review on LMICs found that low perceived treatment need and low motivation were reported as the most common treatment barriers for substance use treatment, followed by stigma, not perceiving a problem, and structural barriers (e.g., cost, limited availability) (Sarkar et al., 2021). However, none of the studies included in the review were from LMICs in the Americas, and the inclusion criteria did not cover all mental disorders, only substance use.

In the Americas, mental and substance use disorders have been considered among the most important public health concerns. In this region, the burden related to mental health has been estimated between 10.5% and 19% of disability adjusted life years (DALYs) and 22% to 34% of years lived with disability (YLDs) (Kohn et al., 2018; Vigo, 2019). Despite this, only a small proportion of people with mental or substance use disorders receive adequate treatment for their condition (Alonso et al., 2018; Degenhardt et al., 2017; Thornicroft et al., 2017; Vigo et al., 2020).

We have previously estimated that, in the Americas, about one in four persons with any 12-month mental disorder had received any kind of treatment (Borges et al., 2020). This treatment gap is consistent with other regional studies that estimated a prevalence of 71.2% persons that required care but did not obtain it (Kohn et al., 2018). There is evidence of variation in treatment gap by disorder severity and by sub-region. Kohn et al. (2018) found that the treatment gap for severe mental disorders in high-income countries in North America (i.e., Canada and the United States) was 53.2%, whereas it reached 78.8% in Mesoamerica (i.e., Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, and Panama, all of them LMICs). At the national level, a striking treatment gap of 95% was reported for Guatemala (Kohn et al., 2018).

Perceived treatment need has an important role in treatment seeking and, potentially, in attitudinal barriers. A recent article with the general population in the United States (Moeller et al., 2020) found that low perception of treatment need is prevalent in 77% of those with substance use disorders. Moreover, the authors found that perceived treatment need is stable and even increases over time (up to 84%). If this pattern is found in LMICs in the Americas it would imply more complex challenges considering that internationally, treatment seeking latency ranges from 1 to 30 years (Wang et al., 2007b).

While it could be assumed that in LMICs the treatment gap for mental disorders might be mainly related to financial hardship and poverty, other factors may play a key role as well.

Personal and structural barriers for not seeking treatment in the region have been sporadically reported, including stigma and misconceptions about the natural history of the disease, among others (Saldivia et al., 2004; Santos Cruz et al., 2013). A previous study from the World Mental Health (WMH) Initiative has reported on the barriers to seeking help, classifying the participating countries according to income categories (Andrade et al., 2014). However, previous literature has not specifically focused on the Americas, and it has not considered potentially relevant determinants of help-seeking behaviors such as disease severity, stigma, and attitude toward treatment, among others.

The region of the Americas is full of contrasts, comprising some of the richest and poorest countries in the world with large variations in the organization of mental health services (Pan American Health Organization, 2013). To expand treatment coverage and to reduce the mental health treatment gap in the region, detailed comparable data and analyses are needed, but rarely available. Review of the current epidemiologic literature suggests that few reports from the region have considered the role of disease severity and its relationship to several types of barriers to treatment.

Therefore, the aim of this article is to describe the structural and attitudinal barriers for seeking treatment among those with 12-month mental and substance use disorders, based on WMH data from the countries of the region of the Americas. We also assessed their socio-demographic correlates and their association with disease severity, evaluating the heterogeneity across countries by testing how individual countries vary from the overall pooled estimates for the region.

2. Methods

2.1. Participants

Respondents were from seven WHO WMH surveys carried out in six countries in the Region of the Americas (two from Colombia): two surveys in countries classified at the time of data collection as LMICs (Colombia-national and Peru), three in upper-middle-income countries (Brazil, Colombia-Medellin and Mexico) and two in high-income countries (Argentina and the United States). The U.S. survey was based on a nationally representative household sample, three surveys (Argentina, Colombia-national and Mexico) were representative of urban areas, and the remaining three were representative of selected metropolitan areas (Sao Paulo, Brazil, Medellin, Colombia- and Metropolitan Lima, Huancayo, Iquitos, Arequipa, and Chiclayo, Peru). In all surveys, trained lay interviewers conducted face-to-face interviews with respondents aged at least 18 years old. Respondents were selected using multistage household probability samples. The total sample size was 35,645. The weighted average response rate across all countries was 79.8% (supplementary Table S1). The local human research committees of each survey gave their respective approval. Subsampling procedures to reduce respondent burden were used, as described elsewhere (Heeringa et al., 2008). Among the total sample, 6710 participants met criteria for a mental disorder in the last 12 months. In this report, we focused on the respondents that did not seek mental health services but met criteria for a mental disorder in the last 12 months (n= 4648), a group that is clearly in need of treatment. We focused only on past-year diagnosis to reduce memory bias in both psychiatric symptoms and reasons for not seeking treatment.

2.2. Instrument

The interviewers administered, face-to-face, the computer-assisted interview-version of the WMH Survey Initiative-Composite International Diagnostic Interview (CIDI) (Kessler and Ustun, 2004; Robins et al., 1988); this fully structured diagnostic interview yielded-DSM-IV diagnoses.

All measures that were used are embedded within the CIDI. Following WHO guidelines (see Pennell et al. (2008) for further details), the original English version of the CIDI was translated, back-translated, and harmonized in different languages for use in the WMH surveys. Classification accuracy of CIDI diagnoses compared with diagnoses from blinded clinical reappraisal interviews has been reported with an Area Under the Curve (AUC) of 0.76 for any disorder and ranging from 0.62 to 0.93 for individual disorders (Haro et al., 2006). Disorders that were considered in this report include the standard disorders measured in the CIDI. The CIDI instrument also includes the Sheehan Disability Scales (Sheehan et al., 1996) which evaluate how much the symptoms interfere with four different areas of life on a scale from 0 to 10. The Spanish Language version has good indicators of validity (discriminating between those with and without depression with an AUC of 0.81) and internal consistency (α = 0.83) (Luciano et al., 2010).

2.3. Measures

2.3.1. Disorders

As in our previous report about treatment for mental disorders in the Americas (Borges et al., 2020), we identified those respondents positive for at least one of the following WMH-CIDI mental and substance use disorders: (1) affective disorders: major depressive disorder (MDE), dysthymia and bipolar disorder (we used a broad definition that included bipolar I, II and subthreshold, defined as a history of recurrent sub-threshold hypomania in the presence of MDE, or a history of recurrent hypomania in the absence of recurrent MDE, or a history of recurrent sub-threshold hypomania in the absence of concurrent MDE (Kessler et al., 2006)); (2) anxiety disorders: panic disorder, agoraphobia, social phobia, specific phobia, adult separation anxiety disorder, generalized anxiety disorder and posttraumatic stress-disorder; (3) substance use disorders: alcohol and drug abuse and dependence and (4) behavioral disorders: attention deficit/hyperactive disorder, and intermittent explosive disorder.

2.3.2. Disorder severity

WMH-CIDI uses trans-diagnostic criteria to classify the clinical presentations of disorders as serious, moderate, or mild (Demyttenaere et al., 2004; Evans-Lacko et al., 2018). People who meet criteria for any 12-month DSM-IV disorder were classified as suffering a serious disorder if they had any of the following: (a) high level of impairment on the Sheehan Disability Scales (SDS); (b) a suicide attempt in the past 12 months; (c) substance dependence with a physiological dependence syndrome; or (d) 12-month bipolar I disorder (Endicott et al., 1976; Sheehan et al., 1996). Respondents not classified as having a serious disorder were classified as moderate if impairment was rated as at least moderate in any SDS domain or if the respondent had substance dependence without a physiological dependence syndrome. All other respondents were classified as mild.

2.3.3. Barriers and reasons for not using services

2.3.3.1. Perceived treatment need

Respondents with any 12-month mental or substance use disorder who reported no use of mental health services were asked whether there was a time in the past 12 months when they felt they might have needed to see a professional for problems with their emotions, nerves, or mental health.

As described elsewhere (Borges et al., 2020), treatment options for mental health services included psychiatrists, other mental health specialists (i.e., psychologists, counselors, psychotherapists, mental health nurses and social workers), general medical practitioners (i.e., family physicians, general practitioners and other medical doctors, nurses, occupational therapists, or other health care professionals); human services, (e.g., religious or spiritual advisors), and complementary-alternative medicine (e.g., self-help groups, any other healers).

Those who did not think they needed help or thought they needed help for less than four weeks were categorized as having “low perceived need”. Respondents who reported needing help for more than 4 weeks were categorized as “perceived need”, and then were asked about the potential structural and attitudinal barriers that may have led to not receiving the care they felt they needed.

2.3.3.2. Structural barriers

As in previous studies from the WMH surveys (Andrade et al., 2014), structural barriers were identified by respondents’ endorsement of the following statements: financial barriers: “My health insurance would not cover this type of treatment”, or “I was concerned about how much money it would cost”; availability: “I was unsure about where to go or who to see”, “I could not get an appointment”, or “I was not satisfied with available services”; transportation: “I had problems with things like transportation, childcare, or scheduling that would have made it hard to get to treatment”; inconvenient: “I thought it would take too much time or be inconvenient”. Those who reported at least one of those, were coded positive in a composite variable labeled “any structural barrier”.

2.3.3.3. Attitudinal barriers and reasons

Attitudinal barriers were identified by endorsement of the following statements: wanted to handle on onés own: “I wanted to handle the problem on my own”; perceived ineffectiveness: “I didn’t think treatment would work”, or “I received treatment before and it did not work”; stigma: “I was concerned about what others might think if they found out I was in treatment”, or “I was scared about being put into a hospital against my will”; thought it would get better: “I thought the problem would get better by itself”; problem was not severe: “The problem didn’t bother me very much”, or “The problem went away by itself, and I did not really need help”. Respondents who endorsed more than one attitudinal barrier/reason for not seeking help were coded positive for “any attitudinal barrier”.

2.3.4. Socio-demographic correlates

Socio-demographic variables were age (categorized as 18–34, 35–49, 50–64 and 65+ years), sex, and marital status (married/cohabitating, previously married, never married). Completed years of education and family income were grouped into four categories: low, low-average, high-average and high, based on country-specific distributions, as detailed elsewhere (Evans-Lacko et al., 2018). After some preliminary analysis, due to sample size limitations in the statistical models for attitudinal barriers, we further dichotomized age, education, and income, by collapsing the first two and the last two categories for these models.

2.4. Data analysis strategy

The data were weighted to adjust for differential probabilities of selection and nonresponse. Estimates of standard errors for proportions were obtained by the Taylor series-linearization method implemented in the SAS’ survey analysis procedures (SAS Institute Inc, 2017). Logistic regression-analysis (Hosmer and Lemeshow, 2000) was performed to study socio-demographic correlates. Estimates of standard errors of odds ratios from logistic regression coefficients were obtained, along with their corresponding 95% confidence intervals, adjusted for design effects. Statistical significance was evaluated with two-sided design-based tests with α=0.05. All models included controls for survey and mental disorders.

First, we estimated the proportion of individuals reporting low perceived treatment need or any structural and attitudinal barrier, by disorder severity and by country, as well as pooled across the region, among those respondents with mental disorders who did not seek treatment. Second, we estimated the proportion of respondents with each individual structural and attitudinal barrier by severity for each country and pooled across the region. Third, we examined between-country variation in associations of barriers with sociodemographic variables by including all predictor-by-survey interactions in logistic regression models using a dummy coding scheme that kept the product of all country-specific odds ratios (ORs) equal to 1. This method allowed us to detect significant between-country variation with respect to the overall effect, by evaluating the statistical significance of deviation of within-survey coefficients from the median value (Mortier et al., 2018). The reported survey-specific ORs show to what extent the survey-specific effect deviates from the overall effect. For example, if the reported OR for females (versus males) in the United States is 1.5, then it would be necessary to multiply it by the reported overall effect (e.g., OR = 1.2) to obtain the survey-specific effect in the United States (i.e., OR = 1.8). To study the attitudinal barriers further, we also modelled the most important reason in the Americas for not seeking treatment despite perceiving need: people with a 12-month disorder wanting to handle the problem on their own.

2.5. Statement of ethics

The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All participants gave informed consent and the Ethical Review Board of the responsible research institutions in each country gave approval of the survey.

3. Results

3.1. Barriers for not seeking treatment

Among 4648 respondents with mental disorders but no service use in the past 12 months, low perceived treatment need was reported by 1998 respondents (43%). People with moderate or mild disorders reported low perceived treatment need significantly more frequently than those with a severe disorder (49.7% vs. 31.9%; p <0.001) (Table 1). This pattern was observed across countries, reaching a higher than twofold difference in perceived need by level of severity in Argentina (48.4% vs. 22.2%; p =0.002). The highest proportion of low perceived treatment need was found in Brazil among those with moderate/mild disorder severity (63.0%). However, also in that level of severity, close to half of respondents in Argentina (48.4%) and the United States (48.8%) reported low perceived treatment need. Among those with severe disorders, respondents in Medellin, Colombia (46.4%) and Brazil (41.0%) reported high prevalence of low perceived treatment need. Attitudinal barriers were endorsed by a higher proportion of respondents than structural barriers (for severe disorders: 63.9% vs. 26.6% respectively and for mild/moderate disorders: 48.2% vs. 11.4%, respectively). Both structural and attitudinal barriers were more likely to be reported by those with severe cases than mild to moderate cases.

Table 1.

Barriers for not seeking treatment among all respondents with 12-month mental disorders who did not use services in that period, by severity of disorder. WMH Americas surveys.

Low perceived need for treatment Any structural barrier Any attitudinal barrier
Survey n Severe Moderate/Mild χ21 p-value Severe Moderate/Mild χ21 p-value Severe Moderate/Mild χ21 p-value
% (S.E.) % (S.E.) % (S.E.) % (S.E.) % (S.E.) % (S.E.)
Argentina 379 22.2 (5.7) 48.4 (4.6) 9.8 0.002 22.4 (5.4) 9.0 (2.0) 4.7 0.031 70.1 (5.5) 51.4 (4.5) 5.5 0.02
Brazil 909 41.0 (3.9) 63.0 (2.7) 22.1 <0.001 25.0 (3.6) 9.7 (1.7) 16.9 <0.001 52.9 (3.7) 33.5 (2.6) 20.9 <0.001
Colombia 706 24.3 (5.0) 42.1 (3.2) 10.8 0.001 31.7 (6.6) 13.0 (1.7) 6.9 0.009 73.6 (5.0) 56.3 (3.2) 9.8 0.002
Medellin, Colombia 411 46.4 (6.7) 58.9 (3.8) 2.8 0.094 19.5 (4.2) 11.6 (2.6) 2.7 0.101 52.1 (6.7) 39.4 (3.8) 2.9 0.092
Mexico 550 25.8 (4.1) 41.9 (3.2) 11.7 <0.001 29.9 (4.5) 15.6 (1.9) 9.8 0.002 68.0 (5.1) 55.1 (3.2) 5.3 0.022
Peru 304 24.7 (5.3) 35.4 (3.0) 2.1 0.144 29.7 (7.5) 20.1 (2.1) 1.4 0.229 68.0 (5.1) 61.3 (3.0) 0.9 0.334
United States 1389 25.9 (3.3) 48.8 (1.8) 41.1 <0.001 28.6 (2.9) 9.1 (1.1) 50.8 <0.001 72.7 (3.1) 50.0 (1.8) 38.4 <0.001
Overall 4648 31.9 (1.9) 49.7 (1.1) 67.5 <0.001 26.6 (1.7) 11.4 (0.7) 70.5 <0.001 63.9 (1.9) 48.2 (1.1) 52.9 <0.001

n shown is the denominator n of all respondents with 12-month mental disorders who did not use services in that period in each country.

Abbreviations: SE, Standard Error

Analyses performed on part II sample

3.2. Specific treatment barriers by severity

3.2.1. Structural barriers

Among those who reported treatment need but did not access treatment, we further analyzed the structural and attitudinal barriers. Tables 2 and 3 show the proportion of respondents with perceived treatment need (n=2650) reporting each structural and attitudinal barrier. First, structural barriers were reported less frequently in HIC: Argentina (21.1%) and the United States (22.1%), and most frequently in LMIC: e.g., Brazil and Peru (32.5%) (Table 2). Overall, the most frequent structural barriers reported were financial (18.5%) and availability (17.7%), with a significantly higher proportion of severe cases (27.2% and 26.8% respectively) reporting those barriers as compared to moderate (18.3% and 17.0% respectively) and mild cases (11.4% and 10.7% respectively).

Table 2.

Structural barriers for not seeking treatment among the subgroup with 12-month mental disorders who perceived a need for mental health care but did not access any, according to level of severity and survey. WMH Americas surveys.

Any severity Severe Moderate Mild
Structural barrier Survey Total with need but no service (n) n % (S.E.) n % (S.E.) n % (S.E.) n % (S.E.) χ22 p-value
Financial
Argentina 234 32 13.1 (3.3) 16 23.9 (8.0) 8 9.5 (3.9) 8 6.0 (2.7) 3.9 0.145
Brazil 431 103 25.0 (3.6) 52 32.1 (5.1) 39 24.5 (4.9) 12 13.6 (4.9) 14.3 <0.001
Colombia 430 95 19.1 (2.4) 27 26.3 (6.6) 44 18.2 (3.8) 24 14.7 (3.7) 2 0.360
Medellin, CO 196 33 19.7 (3.4) 16 27.1 (6.6) 13 20.9 (5.6) 4 -- 5.1 0.079
Mexico 352 77 18.8 (2.8) 26 23.5 (5.7) 36 23.6 (4.0) 15 10.9 (3.4) 7.5 0.025
Peru 203 44 21.2 (2.9) 11 25.9 (6.0) 19 20.9 (4.2) 14 19.5 (5.9) 0.9 0.647
United States 804 124 15.0 (1.7) 48 26.0 (4.2) 55 14.5 (2.4) 21 8.8 (2.4) 11.6 0.003
Overall 2650 508 18.5 (1.1) 196 27.2 (2.3) 214 18.3 (1.5) 98 11.4 (1.5) 34.9 <0.001
Availability
Argentina 234 31 11.7 (2.4) 11 14.4 (4.3) 13 11.9 (4.0) 7 8.4 (4.0) 1.8 0.404
Brazil 431 101 22.7 (2.5) 55 30.5 (5.1) 32 19.4 (3.2) 14 14.8 (4.6) 5 0.083
Colombia 430 91 20.3 (2.6) 27 30.8 (7.6) 39 18.4 (3.8) 25 14.9 (3.5) 2.6 0.275
Medellin, CO 196 36 21.3 (4.1) 14 21.7 (5.9) 19 32.8 (7.5) 3 -- 13.8 0.001
Mexico 352 94 22.1 (2.8) 38 33.5 (6.5) 32 21.2 (4.1) 24 15.0 (4.0) 6.6 0.038
Peru 203 40 18.8 (3.0) 12 28.1 (9.5) 16 19.8 (4.7) 12 13.7 (3.6) 2.5 0.291
United States 804 107 12.6 (1.5) 42 24.2 (3.5) 43 11.3 (2.0) 22 6.8 (1.2) 17.9 <0.001
Overall 2650 500 17.7 (1.0) 199 26.8 (2.2) 194 17.0 (1.4) 107 10.7 (1.1) 36.6 <0.001
Transportation
Argentina 234 10 -- 3 -- 3 -- 4 -- 1.5 0.472
Brazil 431 47 9.6 (1.7) 29 15.5 (2.9) 14 8.1 (3.4) 4 -- 17.9 <0.001
Colombia 430 37 6.5 (1.2) 12 11.3 (4.1) 15 4.7 (1.6) 10 5.4 (2.2) 2.3 0.320
Medellin, CO 196 8 4.2 (1.6) 4 -- 4 -- 0 0 ++ ++
Mexico 352 34 7.5 (1.6) 14 11.0 (2.8) 12 8.7 (2.8) 8 4.0 (1.7) 5.6 0.061
Peru 203 16 5.8 (1.3) 5 10.2 (3.3) 7 5.3 (1.5) 4 4.5 (2.3) 2.7 0.260
United States 804 52 5.6 (1.1) 27 13.4 (3.0) 19 4.9 (1.2) 6 1.5 (0.6) 15.6 <0.001
Overall 2650 204 6.5 (0.6) 94 11.7 (1.4) 74 5.7 (0.9) 36 3.1 (0.6) 35.8 <0.001
Inconvenient
Argentina 234 14 6.8 (2.3) 3 -- 6 9.4 (4.7) 5 -- 1.4 0.496
Brazil 431 41 8.0 (1.5) 27 13.8 (3.7) 12 6.0 (2.3) 2 -- 9.5 0.009
Colombia 430 47 9.6 (1.9) 15 13.2 (3.9) 20 10.1 (3.6) 12 6.0 (2.4) 2.3 0.322
Medellin, CO 196 11 5.8 (2.0) 7 10.1 (3.8) 4 -- 0 0 ++ ++
Mexico 352 47 13.0 (2.1) 18 19.7 (5.3) 21 15.7 (3.4) 8 5.7 (2.2) 9 0.012
Peru 203 33 14.7 (3.2) 12 28.0 (8.2) 14 14.0 (4.3) 7 9.9 (4.2) 4.3 0.119
United States 804 86 10.0 (1.3) 32 18.7 (3.2) 39 10.0 (1.6) 15 4.5 (1.3) 14.2 <0.001
Overall 2650 279 9.8 (0.7) 114 15.0 (1.6) 116 9.9 (1.1) 49 5.0 (0.8) 28.8 <0.001
Any structural barrier
Argentina 234 51 21.1 (3.7) 20 28.8 (6.4) 20 22.4 (6.6) 11 10.8 (4.1) 6 0.050
Brazil 431 138 32.5 (4.0) 74 42.3 (5.6) 45 29.3 (5.4) 19 21.0 (5.5) 8.9 0.012
Colombia 430 128 27.0 (2.7) 40 41.8 (7.7) 57 25.6 (4.5) 31 17.3 (3.9) 5.6 0.061
Medellin, CO 196 56 31.0 (4.3) 24 36.3 (7.1) 25 39.5 (7.4) 7 -- 10.5 0.006
Mexico 352 129 30.4 (3.2) 46 40.2 (6.8) 50 32.2 (4.7) 33 21.9 (4.5) 5.5 0.064
Peru 203 70 32.5 (2.4) 17 39.5 (9.0) 30 30.7 (4.8) 23 31.6 (5.4) 0.8 0.679
United States 804 183 22.1 (2.2) 70 38.5 (3.5) 76 20.4 (2.9) 37 13.7 (2.4) 43.4 <0.001
Overall 2650 755 27.0 (1.2) 291 39.1 (2.4) 303 26.2 (1.8) 161 17.6 (1.6) 54.2 <0.001
--

Percentage less than twice the SE or sample size < 30

++

χ2 test was not computed due to an empty cell

Abbreviations: SE, Standard Error

Analyses performed on part II sample

Table 3.

Attitudinal barriers for not seeking treatment among the subgroup with 12-month mental disorders who perceived a need for mental health care but did not access any, according to level of severity and survey. WMH Americas surveys.

Any severity Severe Moderate Mild
Attitudinal barrier Survey Total with need but no service (n) n % (S.E.) n % (S.E.) n % (S.E.) n % (S.E.) χ22 p-value
Wanted to handle own
Argentina 234 153 60.9 (4.8) 27 38.7 (8.0) 72 70.0 (5.8) 54 73.0 (6.4) 10.4 0.006
Brazil 431 293 66.1 (2.9) 116 65.5 (7.5) 105 67.0 (6.1) 72 65.7 (6.4) 0 0.984
Colombia 430 298 71.7 (3.2) 61 62.5 (6.8) 130 73.1 (5.1) 107 76.8 (4.1) 3.7 0.161
Medellin, CO 196 141 73.4 (4.0) 40 74.0 (6.8) 56 66.4 (6.7) 45 84.1 (6.9) 3.2 0.198
Mexico 352 226 67.1 (3.4) 48 61.4 (7.2) 98 68.6 (4.6) 80 69.6 (5.7) 0.9 0.652
Peru 203 126 65.6 (2.9) 21 52.8 (8.0) 54 64.9 (5.0) 51 72.1 (5.9) 5.1 0.080
United States 804 581 73.2 (1.4) 111 62.7 (3.3) 251 73.9 (2.8) 219 79.0 (2.9) 13.1 0.002
Overall 2650 1818 69.4 (1.1) 424 61.5 (2.7) 766 70.5 (1.9) 628 74.9 (1.9) 15.7 <0.001
Perceived ineffectiveness
Argentina 234 54 24.4 (3.9) 19 30.2 (7.4) 19 25.8 (6.2) 16 16.3 (5.3) 3.2 0.205
Brazil 431 77 16.4 (2.5) 41 20.3 (5.0) 25 14.3 (3.9) 11 13.1 (6.3) 1 0.610
Colombia 430 85 19.6 (2.8) 26 34.4 (7.7) 34 14.6 (3.4) 25 15.5 (2.9) 5 0.085
Medellin, CO 196 39 17.3 (3.0) 19 25.4 (5.9) 16 16.3 (4.8) 4 -- 4.4 0.115
Mexico 352 55 13.2 (1.8) 24 20.1 (4.5) 23 17.2 (3.4) 8 4.6 (1.8) 18.1 <0.001
Peru 203 26 11.3 (2.0) 6 14.6 (5.9) 11 12.1 (2.8) 9 8.9 (3.6) 1.1 0.588
United States 804 140 16.0 (1.3) 46 26.0 (4.4) 58 14.9 (1.7) 36 11.1 (2.3) 7.5 0.024
Overall 2650 476 16.7 (0.9) 181 24.9 (2.4) 186 15.6 (1.3) 109 11.2 (1.4) 23.5 <0.001
Stigma
Argentina 234 4 0.8 (0.4) 3 -- 1 -- 0 0 ++ ++
Brazil 431 41 7.5 (1.1) 27 12.4 (2.5) 13 6.4 (1.7) 1 -- 14.2 <0.001
Colombia 430 59 12.9 (2.0) 23 24.7 (5.8) 24 10.6 (3.1) 12 6.8 (2.4) 7 0.031
Medellin, CO 196 27 15.9 (4.1) 14 25.8 (8.3) 11 13.5 (5.1) 2 -- 3.5 0.175
Mexico 352 43 9.6 (1.4) 20 16.9 (4.2) 16 9.7 (2.1) 7 4.4 (1.9) 7.9 0.020
Peru 203 22 10.4 (2.9) 8 19.5 (6.9) 8 11.0 (4.6) 6 5.7 (2.6) 3.8 0.150
United States 804 77 8.9 (1.2) 38 21.3 (3.2) 28 7.2 (1.6) 11 3.1 (0.9) 23.5 <0.001
Overall 2650 273 9.3 (0.7) 133 17.5 (1.7) 101 8.2 (1.0) 39 3.8 (0.7) 49.4 <0.001
Thougth would get better
Argentina 234 35 13.5 (2.5) 7 10.1 (4.4) 17 17.3 (4.7) 11 12.0 (4.5) 1.4 0.507
Brazil 431 70 15.0 (2.6) 40 20.7 (4.2) 22 14.5 (3.8) 8 6.3 (2.0) 8.8 0.013
Colombia 430 77 17.5 (2.7) 27 29.3 (7.1) 33 16.0 (3.9) 17 10.4 (2.7) 5.7 0.059
Medellin, CO 196 37 17.9 (3.4) 18 25.7 (6.2) 15 19.8 (6.5) 4 -- 9.6 0.009
Mexico 352 71 17.7 (2.3) 24 22.5 (5.0) 29 19.2 (3.5) 18 12.9 (3.9) 2.2 0.330
Peru 203 33 14.7 (2.6) 9 22.2 (9.0) 12 12.4 (3.9) 12 14.3 (4.1) 1 0.610
United States 804 103 11.6 (1.4) 43 23.1 (3.5) 42 10.3 (1.8) 18 5.8 (1.2) 20.7 <0.001
Overall 2650 426 14.7 (0.9) 168 22.3 (2.0) 170 14.2 (1.3) 88 8.7 (1.0) 35.1 <0.001
Problem was not severe
Argentina 234 33 15.8 (3.5) 14 24.5 (7.6) 11 10.6 (4.0) 8 13.4 (6.0) 2.3 0.319
Brazil 431 64 14.8 (2.7) 27 15.6 (3.5) 26 14.9 (4.6) 11 13.1 (5.7) 0.2 0.918
Colombia 430 93 24.4 (4.1) 27 25.5 (5.6) 41 29.6 (6.5) 25 15.3 (3.8) 6.5 0.040
Medellin, CO 196 32 15.8 (3.1) 14 21.7 (6.1) 14 18.1 (5.1) 4 -- 8.4 0.016
Mexico 352 74 21.4 (2.9) 22 23.9 (4.6) 23 14.0 (3.3) 29 26.7 (5.8) 5.9 0.054
Peru 203 57 28.3 (2.8) 14 37.0 (8.8) 27 25.9 (6.3) 16 27.6 (6.0) 1.1 0.570
United States 804 138 16.6 (1.2) 51 27.1 (3.6) 57 15.9 (2.6) 30 10.9 (1.9) 14 0.001
Overall 2650 491 18.9 (1.1) 169 23.3 (1.9) 199 18.7 (1.9) 123 15.3 (1.6) 10.7 0.005
Any attitudinal barrier
Argentina 234 226 96.6 (1.2) 57 90.1 (3.4) 97 99.4 (0.6) 72 100 ++ ++
Brazil 431 395 90.3 (2.0) 158 89.7 (2.9) 149 92.3 (3.0) 88 88.0 (4.5) 0.8 0.684
Colombia 430 415 97.3 (0.7) 93 97.1 (0.7) 182 97.2 (1.3) 140 97.5 (1.4) 0.1 0.972
Medellin, CO 196 188 96.3 (1.6) 58 97.2 (2.1) 77 93.5 (3.5) 53 99.8 (0.2) 4.4 0.110
Mexico 352 324 93.9 (1.4) 82 91.6 (4.0) 133 92.0 (2.2) 109 97.2 (1.3) 4.2 0.121
Peru 203 187 94.1 (1.1) 35 90.3 (4.5) 85 93.1 (2.2) 67 97.1 (1.5) 4 0.139
United States 804 784 97.3 (0.6) 177 97.9 (1.1) 336 97.4 (1.1) 271 96.8 (1.3) 0.4 0.822
Overall 2650 2519 95.3 (0.5) 660 93.9 (1.0) 1059 95.5 (0.8) 800 96.2 (0.9) 3.2 0.200
--

Percentage less than twice the SE or sample size < 30

++

χ2 test was not computed due to an empty cell, or a cell with 100% of cases

Abbreviations: SE, Standard Error

Analyses performed on part II sample

3.2.2. Attitudinal barriers

Regarding attitudinal barriers (Table 3), the vast majority of respondents (95.3% overall and above 90% in all surveys) reported at least one, with no overall differences by severity of disorder. Overall, wanting to handle the problem by themselves was the most common reason for not seeking treatment, ranging from 60.9% in Argentina up to 73.4% in Medellin, Colombia. Stigma was the least cited reason, ranging from 0.8% to 15.9%, also in Argentina and in Medellin, Colombia. Each individual attitudinal barrier was more common in severe cases, except for wanting to handle it on their own, where the opposite was observed.

3.3. Socio-demographic predictors by country

3.3.1. Socio-demographic predictors of structural barriers

Overall, being female, with high-average and low-average educational attainment, and increased severity of disorders were significant correlates of perceiving structural barriers (Table 4). Females were 70% more likely than males to report structural barriers than males. Compared to those with the highest level of education, respondents with low average and high average education had twice the odds of reporting any structural barrier. Similarly, compared to mild cases, moderate and severe cases reported 1.7 and 2.5 the odds, respectively, of structural barriers. Controlling for sociodemographic variables, structural barriers significantly varied by disorder severity (χ2=21.4; p<0.001). Few deviations from the mean were observed for individual countries. In Argentina, previously married respondents, compared to those currently married were more likely to experience any structural barrier, and those with lower income experienced significantly less structural barriers than the average of the region. In Medellin, Colombia those with moderate severity, compared to mild severity, had threefold the odds of reporting any structural barrier. Few other deviations from the overall associations were observed.

Table 4:

Socio-demographic predictors of any structural barrier among the subgroup with 12-month mental disorders who perceived a need for mental health care but did not access any, in the WMH Americas Surveys. Country effect vs. overall effect.

Variable Overall (n = 2650) Argentina (n = 234) Brazil (n = 431) Colombia (n = 430) Medellin, Colombia (n = 196) Mexico (n = 352) Peru (n = 203) United States (n = 804)
aORa (95% CI) aORa (95% CI) aORa (95% CI) aORa (95% CI) aORa (95% CI) aORa (95% CI) aORa (95% CI) aORa (95% CI)
Sex
Female 1.7* (1.2–2.3) 1.3 (0.6–3.0) 1.0 (0.6–1.7) 0.7 (0.4–1.2) 1.1 (0.5–2.7) 1.2 (0.7–2.4) 0.8 (0.3–2.1) 1.0 (0.7–1.5)
Male 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 -
χ21 (p-value) 10.1* (0.001) 0.4 (0.509) 0.0 (0.956) 2.1 (0.150) 0.0 (0.832) 0.5 (0.497) 0.2 (0.685) 0.0 (0.945)
Age
Age 18–34 1.0 (0.4–2.5) 0.4 (0.1–2.0) 0.7 (0.2–3.4) 0.3 (0.0–2.8) 1.6 (0.5–5.5) 0.4 (0.1–1.9) 0.7 (0.3–1.9) 25.4* (3.4–188.6)
Age 35–49 0.8 (0.3–1.9) 0.2* (0.0–0.9) 0.9 (0.2–4.3) 0.2 (0.0–2.4) 1.1 (0.4–3.2) 0.6 (0.1–2.7) 1.4 (0.5–3.8) 30.9* (4.6–208.3)
Age 50–64 0.9 (0.3–2.2) 0.8 (0.2–3.3) 0.6 (0.1–3.3) 0.3 (0.0–3.2) 1.0 - 0.4 (0.1–2.0) 1.0 - 18.8* (2.4–149.8)
Age ≥65 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 -
χ22–3 (p-value) 2.9 (0.409) 6.2 (0.104) 1.5 (0.688) 1.9 (0.588) 0.8 (0.676) 2.6 (0.458) 4.3 (0.115) 13.8* (0.003)
Education
Low 1.5 (0.9–2.5) 0.8 (0.3–2.8) 0.8 (0.3–2.3) 1.5 (0.6–4.0) 2.0 (0.3–15.9) 0.7 (0.3–1.6) 0.7 (0.2–3.0) 1.0 (0.5–2.1)
Low average 1.7* (1.1–2.7) 1.1 (0.3–4.0) 0.6 (0.2–1.6) 1.3 (0.5–3.5) 1.4 (0.4–5.0) 1.1 (0.5–2.7) 1.0 (0.2–4.0) 0.8 (0.4–1.5)
High average 1.8* (1.2–2.8) 0.7 (0.2–2.7) 1.3 (0.5–3.7) 0.9 (0.3–2.6) 1.5 (0.5–4.6) 1.1 (0.5–2.5) 0.8 (0.2–2.5) 0.8 (0.4–1.5)
High 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 -
χ23 (p-value) 8.5* (0.036) 0.6 (0.889) 4.3 (0.230) 1.3 (0.723) 0.8 (0.856) 1.8 (0.622) 0.4 (0.948) 1.0 (0.791)
Marital status
Married-cohabitating 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 -
Previously married 0.9 (0.6–1.2) 2.9* (1.0–8.1) 1.1 (0.5–2.3) 0.8 (0.3–2.0) 0.8 (0.3–2.3) 1.0 (0.4–2.4) 0.6 (0.2–1.7) 0.9 (0.5–1.6)
Never married 1.0 (0.7–1.3) 1.6 (0.6–3.8) 0.6 (0.3–1.3) 1.1 (0.6–2.1) 0.8 (0.4–1.8) 1.3 (0.6–2.6) 1.5 (0.6–3.7) 0.6 (0.4–1.1)
χ22 (p-value) 0.7 (0.714) 4.3 (0.117) 2.4 (0.303) 0.5 (0.791) 0.3 (0.841) 0.5 (0.788) 2.0 (0.367) 2.7 (0.256)
Income
Low 1.2 (0.8–1.7) 0.2* (0.1–0.6) 1.2 (0.5–2.6) 0.9 (0.5–1.6) 2.4 (0.9–6.9) 1.2 (0.5–2.5) 2.2 (0.7–7.2) 0.7 (0.4–1.3)
Low average 1.1 (0.7–1.6) 0.1* (0.0–0.5) 1.7 (0.7–4.2) 1.2 (0.5–3.3) 1.9 (0.4–8.6) 1.3 (0.6–2.8) 2.2 (0.9–5.2) 0.7 (0.3–1.4)
High average 0.9 (0.6–1.4) 0.2* (0.1–0.8) 0.9 (0.4–2.0) 0.9 (0.4–2.0) 2.4 (0.6–9.4) 0.8 (0.4–1.8) 3.6 (0.9–14.1) 0.8 (0.4–1.5)
High 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 -
χ23 (p-value) 2.8 (0.422) 11.9* (0.008) 2.0 (0.575) 0.7 (0.868) 3.0 (0.392) 1.4 (0.700) 4.4 (0.220) 1.4 (0.696)
Severity
Severe 2.5* (1.7–3.6) 1.8 (0.7–4.8) 0.9 (0.4–1.8) 1.0 (0.4–2.3) 1.7 (0.5–5.8) 0.7 (0.3–1.4) 0.5 (0.2–1.4) 1.0 (0.6–1.8)
Moderate 1.7* (1.2–2.4) 1.2 (0.4–3.3) 0.8 (0.4–1.7) 0.9 (0.4–1.8) 3.5* (1.1–11.2) 0.7 (0.3–1.3) 0.6 (0.3–1.3) 0.8 (0.5–1.4)
Mild 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 -
χ22 (p-value) 21.4* (<0.001) 1.7 (0.422) 0.4 (0.810) 0.2 (0.919) 6.5* (0.038) 1.6 (0.453) 2.2 (0.327) 1.3 (0.534)

Model Fit AIC = 1883.0

a

Data are given as adjusted odds ratios (95% confidence interval) unless otherwise indicated

*

Significant at p = .05, 2-sided test

Reference categories are denoted as 1.0 -; Age groups 50–64 and 65+ were collapsed for Peru and Medellin due to cells with zero-counts.

The degrees of freedom for each chi-square test is based upon the number of groups available in each main category

Note: each row shows a separate logistic regression model with any structural barrier as the outcome variable, controlling for the other predictor variables (rows), survey, and all predictor-by-survey interaction dummies. The second column shows the overall adjusted predictor variable effect; the survey columns show to what extent the survey-specific adjusted predictor variable effect deviates from the overall adjusted predictor variable effect. For example, the survey-specific effect for females (versus males) in Mexico can be obtained by multiplying the aOR = 1.6 (the overall effect) by the aOR = 1.3 (the country-specific deviation), i.e., aOR = 2.1

Models include controls for groups of 12-Month DSM-IV / WMH CIDI disorders (any anxiety, any mood, any substance, and any externalized)

Intermittent explosive disorder was not assessed in Mexico and Medellin, were coded as zero; Imputed variables for alcohol and drug dependence were used for Colombia, Mexico, Peru and the U.S.; Lifetime ADHD was used in all countries, and was coded as zero for those with age > 45 in Colombia, Mexico, Peru and the U.S.

3.3.2. Socio-demographic predictors of attitudinal barriers

Overall, being female and having a moderate or severe disorder were associated to a lower proportion of any attitudinal barrier (Table 5). However, while in Argentina respondents with severe disorders were even less prone than the average to report this type of barrier, in the United States and Brazil, respondents were more likely to report it. Based on the high proportion of respondents that reported “wanting to handle it on their own”, we independently analyzed this attitudinal barrier (Table 6). Overall, compared to their counterparts, females and those with severe disorders were less likely to report this barrier. At the country level, respondents with severe disorders in Argentina, younger respondents in Brazil, and previously married respondents in Colombia were significantly less likely to report this barrier.

Table 5:

Socio-demographic predictors of any attitudinal barrier among the subgroup with 12-month mental disorders who perceived a need for mental health care but did not access any, in the WMH Americas Surveys. Country effect vs. overall effect.

Variable Overall (n = 2650) Argentina (n = 234) Brazil (n = 431) Colombia (n = 430) Medellin, Colombia (n = 196) Mexico (n = 352) Peru (n = 203) United States (n = 804)
aORa (95% CI) aORa (95% CI) aORa (95% CI) aORa (95% CI) aORa (95% CI) aORa (95% CI) aORa (95% CI) aORa (95% CI)
Sex
Female 0.4* (0.2–0.8) 2.2 (0.5–8.8) 1.0 (0.4–2.5) 0.9 (0.1–5.1) - - 0.5 (0.1–2.1) 0.8 (0.2–3.5) 1.4 (0.5–3.8)
Male 1.0 - 1.0 - 1.0 - 1.0 - - - 1.0 - 1.0 - 1.0 -
χ21 (p-value) 6.3* (0.012) 1.2 (0.283) 0.0 (0.966) 0.0 (0.869) - 0.9 (0.347) 0.1 (0.724) 0.4 (0.507)
Age
Age 18–49 1.0 (0.5–2.2) 0.7 (0.0–14.4) 1.1 (0.3–3.5) 3.7 (0.9–15.3) 1.4 (0.3–6.8) 0.5 (0.1–2.1) - - 0.5 (0.2–1.8)
Age ≥50 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - - - 1.0 -
χ21 (p-value) 0.0 (0.929) 0.1 (0.795) 0.0 (0.874) 3.2 (0.075) 0.2 (0.692) 0.9 (0.343) - 1.0 (0.307)
Education
Low / Low average 0.6 (0.3–1.1) 1.0 (0.1–6.8) 1.5 (0.5–4.2) 1.6 (0.3–9.6) 0.1* (0.0–0.4) 0.6 (0.2–1.8) 3.4 (0.7–15.5) 3.2* (1.1–9.0)
High average / High 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 -
χ21 (p-value) 2.7 (0.099) 0.0 (0.977) 0.5 (0.492) 0.3 (0.599) 8.4* (0.004) 0.9 (0.348) 2.4 (0.119) 4.8* (0.028)
Marital status
Married-cohabitating 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 -
Previously married 1.1 (0.6–2.3) 0.4 (0.1–2.8) 0.9 (0.3–2.7) 0.5 (0.1–1.7) 1.0 - 1.6 (0.4–6.1) 2.7 (0.3–24.6) 1.2 (0.4–3.6)
Never married 1.2 (0.6–2.2) 0.4 (0.1–3.1) 1.5 (0.3–6.7) 3.3 (0.7–15.1) 0.5 (0.1–3.0) 0.7 (0.2–2.6) 1.4 (0.4–4.3) 1.2 (0.3–4.1)
χ21–2 (p-value) 0.4 (0.800) 5.3 (0.071) 0.3 (0.849) 5.7 (0.057) 0.7 (0.417) 1.0 (0.605) 1.1 (0.567) 0.2 (0.919)
Income
Low / Low average 0.6 (0.3–1.2) 7.7 (0.8–72.0) 0.4 (0.1–1.5) 0.8 (0.1–5.2) 1.0 (0.1–8.7) 0.5 (0.1–1.4) 1.1 (0.2–5.3) 0.7 (0.2–3.0)
High average / High 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 -
χ21 (p-value) 2.1 (0.152) 3.3 (0.071) 1.9 (0.168) 0.1 (0.822) 0.0 (0.979) 1.8 (0.181) 0.0 (0.879) 0.2 (0.678)
Severity
Severe 0.3* (0.1–0.6) 0.0* (0.0–0.4) 4.3* (1.5–12.3) 3.1 (0.8–12.1) 0.2 (0.0–2.7) 1.3 (0.3–5.4) 1.0 (0.2–5.0) 6.0* (1.4–25.0)
Moderate 0.4* (0.2–0.8) 1.0 - 4.3* (1.4–13.0) 2.0 (0.4–10.7) 0.0* (0.0–0.4) 1.1 (0.3–3.4) 0.9 (0.3–3.2) 2.9 (0.9–9.9)
Mild 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 -
χ21–2 (p-value) 12.5* (0.002) 8.1* (0.004) 9.1* (0.011) 2.7 (0.263) 10.7* (0.005) 0.2 (0.910) 0.0 (0.990) 6.5* (0.039)

Model Fit AIC = 642.4

a

Data are given as adjusted odds ratios (95% confidence interval) unless otherwise indicated

*

Significant at p = .05, 2-sided test

Reference categories are denoted as 1.0 -; The Female and Previously Married categories for Medellin, the Moderate severity, and the Age category for Peru were excluded due to cells with zero-counts.

The degrees of freedom for each chi-square test is based upon the number of groups available in each main category

Note: each row shows a separate logistic regression model with any attitudinal barrier as the outcome variable, controlling for the other predictor variables (rows), survey, and all predictor-by-survey interaction dummies. The second column shows the overall adjusted predictor variable effect; the survey columns show to what extent the survey-specific adjusted predictor variable effect deviates from the overall adjusted predictor variable effect. Thus, the survey-specific effect in any given survey can be obtained by multiplying the overall aOR by the survey-specific aOR (i.e., the deviation from the overall effect)

Models include controls for groups of 12-Month DSM-IV / WMH CIDI disorders (any anxiety, any mood, any substance, and any externalized)

Intermittent explosive disorder was not assessed in Mexico and Medellin, were coded as zero; Imputed variables for alcohol and drug dependence were used for Colombia, Mexico, Peru and the U.S.; Lifetime ADHD was used in all countries, and was coded as zero for those with age > 45 in Colombia, Mexico, Peru and the U.S.

Table 6:

Socio-demographic predictors of wanting to handle it by their own (attitudinal barrier) among the subgroup with 12-month mental disorders who perceived a need for mental health care but did not access any, in the WMH Americas Surveys. Country effect vs. overall effect.

Variable Overall (n = 2650) Argentina (n = 234) Brazil (n = 431) Colombia (n = 430) Medellin, Colombia (n = 196) Mexico (n = 352) Peru (n = 203) United States (n = 804)
aORa (95% CI) aORa (95% CI) aORa (95% CI) aORa (95% CI) aORa (95% CI) aORa (95% CI) aORa (95% CI) aORa (95% CI)
Sex
Female 0.7* (0.6–1.0) 0.9 (0.5–1.7) 0.8 (0.5–1.2) 1.3 (0.7–2.2) 1.0 (0.5–2.1) 1.0 (0.6–1.7) 1.1 (0.6–2.2) 1.0 (0.6–1.4)
Male 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 -
χ21 (p-value) 5.1* (0.025) 0.1 (0.814) 1.1 (0.284) 0.6 (0.428) 0.0 (1.000) 0.0 (0.935) 0.1 (0.709) 0.0 (0.847)
Age
Age 18–49 1.2 (0.9–1.8) 1.8 (0.7–4.4) 0.5* (0.3–1.0) 0.9 (0.4–2.4) 1.8 (0.7–4.7) 0.7 (0.3–1.8) 1.1 (0.3–3.4) 0.8 (0.5–1.4)
Age ≥50 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 -
χ21 (p-value) 1.3 (0.263) 1.7 (0.188) 4.3* (0.038) 0.0 (0.852) 1.7 (0.198) 0.5 (0.488) 0.0 (0.886) 0.6 (0.452)
Education
Low / Low average 1.1 (0.8–1.5) 0.7 (0.3–1.8) 0.9 (0.5–1.7) 1.1 (0.6–2.1) 1.3 (0.5–3.0) 1.0 (0.6–1.9) 0.9 (0.5–1.8) 1.1 (0.7–1.7)
High average / High 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 -
χ21 (p-value) 0.6 (0.444) 0.6 (0.448) 0.0 (0.836) 0.1 (0.711) 0.3 (0.587) 0.0 (0.934) 0.0 (0.868) 0.2 (0.689)
Marital status
Married-cohabitating 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 -
Previously married 1.4 (0.9–2.1) 0.6 (0.2–1.7) 0.9 (0.4–1.7) 0.4* (0.2–1.0) 1.2 (0.3–4.5) 2.1 (0.9–5.1) 1.7 (0.5–6.5) 0.9 (0.5–1.6)
Never married 1.0 (0.8–1.4) 0.6 (0.3–1.4) 1.3 (0.6–2.8) 1.7 (0.8–3.3) 1.1 (0.5–2.6) 1.2 (0.7–2.1) 0.9 (0.4–1.7) 0.6 (0.4–1.0)
χ22 (p-value) 2.7 (0.264) 1.8 (0.397) 0.7 (0.689) 7.4* (0.025) 0.2 (0.925) 2.9 (0.229) 0.9 (0.629) 3.3 (0.188)
Income
Low / Low average 0.8 (0.7–1.1) 2.2 (0.9–5.1) 0.7 (0.4–1.2) 1.3 (0.8–2.2) 0.7 (0.3–1.6) 0.9 (0.5–1.5) 0.8 (0.4–1.5) 0.9 (0.6–1.4)
High average / High 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 -
χ21 (p-value) 1.7 (0.187) 3.1 (0.077) 1.4 (0.232) 1.0 (0.311) 0.5 (0.459) 0.1 (0.707) 0.5 (0.489) 0.2 (0.663)
Severity
Severe 0.5* (0.3–0.7) 0.4* (0.2–1.0) 2.1 (0.9–4.9) 0.9 (0.5–1.9) 1.1 (0.4–3.1) 1.3 (0.6–2.7) 0.8 (0.4–1.8) 1.0 (0.6–1.6)
Moderate 0.8 (0.6–1.0) 1.3 (0.6–2.8) 1.5 (0.8–2.9) 1.1 (0.6–2.0) 0.4 (0.2–1.1) 1.3 (0.7–2.3) 0.9 (0.4–2.0) 1.0 (0.6–1.7)
Mild 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 - 1.0 -
χ22 (p-value) 17.8* (<0.001) 6.2* (0.045) 3.6 (0.166) 0.1 (0.945) 6.0* (0.050) 1.0 (0.621) 0.2 (0.899) 0.1 (0.964)

Model Fit AIC = 2003.4

a

Data are given as adjusted odds ratios (95% confidence interval) unless otherwise indicated

*

Significant at p = .05, 2-sided test

Reference categories are denoted as 1.0 −.

The degrees of freedom for each chi-square test is based upon the number of groups available in each main category

Note: each row shows a separate logistic regression model with handle own as the outcome variable, controlling for the other predictor variables (rows), survey, and all predictor-by-survey interaction dummies. The second column shows the overall adjusted predictor variable effect; the survey columns show to what extent the survey-specific adjusted predictor variable effect deviates from the overall adjusted predictor variable effect. Thus, the survey-specific effect in any given survey can be obtained by multiplying the overall aOR by the survey-specific aOR (i.e., the deviation from the overall effect)

Models include controls for groups of 12-Month DSM-IV / WMH CIDI disorders (any anxiety, any mood, any substance, and any externalized)

Intermittent explosive disorder was not assessed in Mexico and Medellin, were coded as zero; Imputed variables for alcohol and drug dependence were used for Colombia, Mexico, Peru and the U.S.; Lifetime ADHD was used in all countries, and was coded as zero for those with age > 45 in Colombia, Mexico, Peru and the U.S.

4. Discussion

While the WMH surveys is one of the largest transcultural projects ever done in psychiatric epidemiology, with large sample sizes, respondents with a 12-month mental disorder and no past 12-month service use are a reduced group of people. Because some of our data are sparce for some of the individual surveys included here, we focus our discussion on overall findings, with emphasis on trends of the data instead of plain “statistical significance”. Our findings indicate that 43% of people with a 12-month mental or substance use disorder did not seek services because of low perceived treatment need, while 57% perceived a need, but did not access services due to a combination of structural and attitudinal barriers. In light of the low levels of coverage for mental and substance use disorders globally and in the Americas (Borges et al., 2020; Wang et al., 2007a), these findings offer valuable insights for clinicians and decision-makers. Low perceived need may reflect two very different situations: first, it may reflect an inability to adequately gauge one’s own need for services that are unequivocally required, such as for severe major depressive and bipolar disorders; second, it may represent an informed personal decision in the context of milder clinical presentations. Indeed, research has shown that up to 20% of people with major depressive disorder recover on their own, so decisions to forego mental health services may be warranted both from a clinical and public health perspective (Boerema et al., 2017). Our data are consistent with these considerations: low perceived need was a reason not to seek services most frequently in people with milder disorders (50%) vs. people with severe disorders (32%). Given that people with severe disorders do require treatment (since our definition includes high levels of disability, substance use disorders, suicide attempts, or bipolar disorder type I during the past 12 months), it is concerning to find that a third of them did not perceive such need. This may signal the need to strengthen (a) public messaging efforts highlighting the importance of treating mental disorders, particularly those at the severe end of the spectrum, and the risks of untreated severe mental illness; and (b) screening practices for mental disorders at the primary care level to broadly deliver targeted messages for people with detectable severe syndromes. Also, it is noteworthy that net perceived treatment need in the Americas might be associated with immigration status, as suggested by previous studies from the United States (Breslau et al., 2017; Breslau et al., 2020; Villatoro et al., 2018), where more than half of its foreign-born population arrived from Latin America and the Caribbean (OECD et al., 2011).

The majority of people who did not access services despite having a 12-month disorder (57%) perceived treatment need but reported a variety of structural or attitudinal reasons for not receiving care. Throughout the region, attitudinal barriers were more frequently endorsed than structural barriers, and both types of barriers were reported more frequently by respondents with severe disorders (except for “wanting to handle the problem on their own”, which we discuss below). The most frequent structural barriers were financial concerns and availability of services, and they were highly prevalent for severely affected individuals, more than a fourth of whom cited them as reasons why they did not get the care they needed. Of note, structural barriers were the lowest in the two countries that qualified as high-income countries (HICs) at the time of the survey, Argentina (21.1%) and the United States (22.1%), whereas structural barriers in the LMICs in our sample were reported by a range of 27% to 32.5% of respondents. That is, in the LMICs close to a third of the persons that did not access treatment would be benefited by policy changes such as universal health care and increased availability of easy-to-access and low-cost treatment options.

Another important finding was that a great proportion of respondents reported they wanted to deal with their symptoms on their own. Interventions may need to be more focused on helping people help themselves. This has two main implications. First, public mental health interventions should include psychoeducation that may serve as toolkit to teach basic strategies to address mental health problems. A possible strategy could be self-guided internet-based interventions, which have been explored but not fully implemented in LMIC settings (Fu et al., 2020). Second, by offering self-help interventions for mild cases, outreach and outpatient services could focus on the moderate and severe cases.

A couple of caveats with respect to these analyses are in order. First, the distinction between HICs and LMICs may not be the best framework to explain the differences in prevalence of structural barriers described above. Indeed, the country that has the lowest level of “any structural barrier” was Argentina, which despite meeting criteria for HIC at the time of the survey, is a LMIC at the time of writing. It is more likely that the low structural barriers in Argentina were due to relatively high public health spending, and high level of mental health resources, especially psychologists and, to a lesser extent, psychiatrists (Organización Mundial de la Salud, 2011). Second, some of the “attitudinal barriers” we have identified are not necessarily barriers stricto sensu. The most prevalent attitudinal barrier was “I wanted to handle the problem on my own”, which together with “I thought the problem would get better by itself” presents a similar complexity to the one we described in our “low perceived need” category: as referenced above (Boerema et al., 2017), up to 20% of people with depression do get better on their own so a proportion of these respondents may be right in advancing these reasons not to seek services despite perceiving a need. In addition to these caveats, other limitations include that only six countries in the Americas are represented, and that not all surveys reflect the within-country regional heterogeneity. Our surveys mainly included urban populations, so it is possible that we have underestimated structural barriers that are likely to be greater in rural areas due to fewer services. While our data preclude testing this, it is noteworthy that Handley et al. (2014) also found greater perceived attitudinal than structural barriers to getting into treatment in a rural population of Australia. Having said that, there is no other source of primary mental health data in the region of comparable quality and methodological consistency. Another important limitation is that due to our focus on people that met 12-month disorder criteria, in some countries the sample size was too small, and some analyses were not able to be performed. Finally, the cross-sectional nature of the survey precludes any causal interpretation of the findings.

Despite the limitations, the implications of these findings for clinical and public health practice are relevant. The fact that women and people of lower educational levels had higher odds of perceiving structural barriers may signal discrimination toward women and unwarranted complexities in accessing mental health services by people unfamiliar with bureaucratic processes. Also, people with more severe disorders also have increased likelihood of running into structural barriers, which may indicate insufficiently facilitated access for the people with the highest level of need. And finally, our results seem to indicate that, in addition to country income level, relatively high financial and human resource investment in mental health does result in more adequate perception of need -awareness of the disease-, less structural barriers, and less stigma-related barriers.

Supplementary Material

Supplement

References

  1. Alonso J, Liu Z, Evans-Lacko S, Sadikova E, Sampson N, Chatterji S, Abdulmalik J, Aguilar-Gaxiola S, Al-Hamzawi A, Andrade LH, Bruffaerts R, Cardoso G, Cia A, Florescu S, de Girolamo G, Gureje O, Haro JM, He Y, de Jonge P, Karam EG, Kawakami N, Kovess-Masfety V, Lee S, Levinson D, Medina-Mora ME, Navarro-Mateu F, Pennell BE, Piazza M, Posada-Villa J, Ten Have M, Zarkov Z, Kessler RC, Thornicroft G, Collaborators W.H.O.W.M.H.S., 2018. Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries. Depress Anxiety 35, 195–208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andrade LH, Alonso J, Mneimneh Z, Wells JE, Al-Hamzawi A, Borges G, Bromet E, Bruffaerts R, de Girolamo G, de Graaf R, Florescu S, Gureje O, Hinkov HR, Hu C, Huang Y, Hwang I, Jin R, Karam EG, Kovess-Masfety V, Levinson D, Matschinger H, O’Neill S, Posada-Villa J, Sagar R, Sampson NA, Sasu C, Stein DJ, Takeshima T, Viana MC, Xavier M, Kessler RC, 2014. Barriers to mental health treatment: results from the WHO World Mental Health surveys. Psychol Med 44, 1303–1317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boerema AM, Ten Have M, Kleiboer A, de Graaf R, Nuyen J, Cuijpers P, Beekman ATF, 2017. Demographic and need factors of early, delayed and no mental health care use in major depression: a prospective study. BMC Psychiatry 17, 367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Borges G, Aguilar-Gaxiola S, Andrade L, Benjet C, Cia A, Kessler RC, Orozco R, Sampson N, Stagnaro JC, Torres Y, Viana MC, Medina-Mora ME, 2020. Twelve-month mental health service use in six countries of the Americas: A regional report from the World Mental Health Surveys. Epidemiol Psychiatr Sci 29, e53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Breslau J, Cefalu M, Wong EC, Burnam MA, Hunter GP, Florez KR, Collins RL, 2017. Racial/ethnic differences in perception of need for mental health treatment in a US national sample. Soc Psychiatry Psychiatr Epidemiol 52, 929–937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Breslau J, Wong EC, Burnam MA, McBain RK, Cefalu M, Beckman R, Collins RL, 2020. Distress, Impairment, and Racial/Ethnic Differences in Perceived Need for Mental Health Treatment in a Nationally Representative Sample. Psychiatry 83, 149–160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Degenhardt L, Glantz M, Evans-Lacko S, Sadikova E, Sampson N, Thornicroft G, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Helena Andrade L, Bruffaerts R, Bunting B, Bromet EJ, Miguel Caldas de Almeida J, de Girolamo G, Florescu S, Gureje O, Maria Haro J, Huang Y, Karam A, Karam EG, Kiejna A, Lee S, Lepine JP, Levinson D, Elena Medina-Mora M, Nakamura Y, Navarro-Mateu F, Pennell BE, Posada-Villa J, Scott K, Stein DJ, Ten Have M, Torres Y, Zarkov Z, Chatterji S, Kessler RC, World Health Organization’s World Mental Health Surveys, c., 2017. Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys. World Psychiatry 16, 299–307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, Angermeyer MC, Bernert S, de Girolamo G, Morosini P, Polidori G, Kikkawa T, Kawakami N, Ono Y, Takeshima T, Uda H, Karam EG, Fayyad JA, Karam AN, Mneimneh ZN, Medina-Mora ME, Borges G, Lara C, de Graaf R, Ormel J, Gureje O, Shen Y, Huang Y, Zhang M, Alonso J, Haro JM, Vilagut G, Bromet EJ, Gluzman S, Webb C, Kessler RC, Merikangas KR, Anthony JC, Von Korff MR, Wang PS, Brugha TS, Aguilar-Gaxiola S, Lee S, Heeringa S, Pennell BE, Zaslavsky AM, Ustun TB, Chatterji S, W. H. O. World Mental Health Survey Consortium, 2004. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 291, 2581–2590. [DOI] [PubMed] [Google Scholar]
  9. Endicott J, Spitzer RL, Fleiss JL, Cohen J, 1976. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33, 766–771. [DOI] [PubMed] [Google Scholar]
  10. Evans-Lacko S, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Benjet C, Bruffaerts R, Chiu WT, Florescu S, de Girolamo G, Gureje O, Haro JM, He Y, Hu C, Karam EG, Kawakami N, Lee S, Lund C, Kovess-Masfety V, Levinson D, Navarro-Mateu F, Pennell BE, Sampson NA, Scott KM, Tachimori H, Ten Have M, Viana MC, Williams DR, Wojtyniak BJ, Zarkov Z, Kessler RC, Chatterji S, Thornicroft G, 2018. Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO World Mental Health (WMH) surveys. Psychol Med 48, 1560–1571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fu Z, Burger H, Arjadi R, Bockting CLH, 2020. Effectiveness of digital psychological interventions for mental health problems in low-income and middle-income countries: a systematic review and meta-analysis. The Lancet Psychiatry 7, 851–864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Handley TE, Kay-Lambkin FJ, Inder KJ, Lewin TJ, Attia JR, Fuller J, Perkins D, Coleman C, Weaver N, Kelly BJ, 2014. Self-reported contacts for mental health problems by rural residents: predicted service needs, facilitators and barriers. BMC Psychiatry 14, 249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Haro JM, Arbabzadeh-Bouchez S, Brugha TS, de Girolamo G, Guyer ME, Jin R, Lepine JP, Mazzi F, Reneses B, Vilagut G, Sampson NA, Kessler RC, 2006. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Int J Methods Psychiatr Res 15, 167–180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Heeringa S, Wells J, Hubbard F, Mneimneh Z, Chiu W, Sampson N, Berglund P, 2008. Sample designs and sampling procedures, In: Kessler RC, Ustun TB (Eds.), The WHO World Mental Health Surveys: Global perspectives on the epidemiology of mental disorders. Cambridge University Press, Cambridge, pp. 14–32. [Google Scholar]
  15. Hosmer DW, Lemeshow S, 2000. Applied logistic regression, 2nd ed. New York: J. Wiley. [Google Scholar]
  16. Kessler RC, Akiskal HS, Angst J, Guyer M, Hirschfeld RM, Merikangas KR, Stang PE, 2006. Validity of the assessment of bipolar spectrum disorders in the WHO CIDI 3.0. J Affect Disord 96, 259–269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kessler RC, Ustun TB, 2004. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 13, 93–121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kohn R, Ali AA, Puac-Polanco V, Figueroa C, Lopez-Soto V, Morgan K, Saldivia S, Vicente B, 2018. Mental health in the Americas: an overview of the treatment gap. Rev Panam Salud Publica 42, e165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lora A, Hanna F, Chisholm D, 2020. Mental health service availability and delivery at the global level: an analysis by countries’ income level from WHO’s Mental Health Atlas 2014. Epidemiology and Psychiatric Sciences 29, 1–12. [DOI] [PubMed] [Google Scholar]
  20. Luciano JV, Bertsch J, Salvador-Carulla L, Tomás JM, Fernández A, Pinto-Meza A, Haro JM, Palao DJ, Serrano-Blanco A, 2010. Factor structure, internal consistency and construct validity of the Sheehan Disability Scale in a Spanish primary care sample. Journal of Evaluation in Clinical Practice 16, 895–901. [DOI] [PubMed] [Google Scholar]
  21. Moeller SJ, Platt JM, Wu M, Goodwin RD, 2020. Perception of treatment need among adults with substance use disorders: Longitudinal data from a representative sample of adults in the United States. Drug Alcohol Depen 209, 107895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mortier P, Auerbach RP, Alonso J, Bantjes J, Benjet C, Cuijpers P, Ebert DD, Green JG, Hasking P, Nock MK, O’Neill S, Pinder-Amaker S, Sampson NA, Vilagut G, Zaslavsky AM, Bruffaerts R, Kessler RC, Collaborators WW-I, 2018. Suicidal Thoughts and Behaviors Among First-Year College Students: Results From the WMH-ICS Project. J Am Acad Child Adolesc Psychiatry 57, 263–273 e261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. OECD, ECLAC, Organization of American States, 2011. International migration in the Americas: First report of the continuous reporting system on international migration in the Americas (SICREMI) 2011. Organization of American States, Washington, D.C. [Google Scholar]
  24. Organización Mundial de la Salud, 2011. Informe sobre los Sistemas de Salud Mental en América del Sur mediante el Instrumento de Evaluación de los Sistemas de Salud Mental (IESM -Organización Mundial De La Salud). Argentina, Brasil, Bolivia, Chile, Ecuador, Paraguay, Perú y Uruguay. Organización Panamericana de la Salud, Organización Mundial de la Salud, Washington, DC. [Google Scholar]
  25. Pan American Health Organization, 2013. WHO-AIMS: Report on Mental Health Systems in Latin America and the Caribbean. PAHO; Washington, DC. [Google Scholar]
  26. Pennell BE, Mneimneh ZN, Bowers A, Chardoul S, Wells JE, Viana MC, Dinkelmann K, Gebler N, Florescu S, He Y, Huang Y, Tomov T, Vilagut Saiz G, 2008. Implementation of the World Mental Health Surveys, In: Kessler RC, Üstün TB (Eds.), The WHO World Mental Health Surveys: Global perspectives on the epidemiology of mental disorders. Cambridge University Press, New York, pp. 33–57. [Google Scholar]
  27. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, Farmer A, Jablenski A, Pickens R, Regier DA, et al. , 1988. The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 45, 1069–1077. [DOI] [PubMed] [Google Scholar]
  28. Saldivia S, Vicente B, Kohn R, Rioseco P, Torres S, 2004. Use of mental health services in Chile. Psychiatr Serv 55, 71–76. [DOI] [PubMed] [Google Scholar]
  29. Santos Cruz M, Andrade T, Bastos FI, Leal E, Bertoni N, Lipman L, Burnett C, Fischer B, 2013. Patterns, determinants and barriers of health and social service utilization among young urban crack users in Brazil. BMC Health Serv Res 13, 536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sarkar S, Tom A, Mandal P, 2021. Barriers and facilitators to substance use disorder treatment in low-and miggle-income countries: a qualitative review synthesis. Substance Use and Misuse 56, 1062–1073. [DOI] [PubMed] [Google Scholar]
  31. SAS Institute Inc, 2017. SAS/STAT® 14.3 User’s Guide. SAS Institute Inc, Cary, NC. [Google Scholar]
  32. Sheehan DV, Harnett-Sheehan K, Raj BA, 1996. The measurement of disability. Int Clin Psychopharmacol 11 Suppl 3, 89–95. [DOI] [PubMed] [Google Scholar]
  33. Thornicroft G, Chatterji S, Evans-Lacko S, Gruber M, Sampson N, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Andrade L, Borges G, Bruffaerts R, Bunting B, de Almeida JM, Florescu S, de Girolamo G, Gureje O, Haro JM, He Y, Hinkov H, Karam E, Kawakami N, Lee S, Navarro-Mateu F, Piazza M, Posada-Villa J, de Galvis YT, Kessler RC, 2017. Undertreatment of people with major depressive disorder in 21 countries. Br J Psychiatry 210, 119–124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Vigo D, 2019. The Burden of Mental Disorders in the Region of the Americas, 2018. Pan American Health Organization, Washington, D.C. [Google Scholar]
  35. Vigo D, Haro JM, Hwang I, Aguilar-Gaxiola S, Alonso J, Borges G, Bruffaerts R, Caldas-de-Almeida JM, de Girolamo G, Florescu S, Gureje O, Karam E, Karam G, Kovess-Masfety V, Lee S, Navarro-Mateu F, Ojagbemi A, Posada-Villa J, Sampson NA, Scott K, Stagnaro JC, Ten Have M, Viana MC, Wu CS, Chatterji S, Cuijpers P, Thornicroft G, Kessler RC, 2020. Toward measuring effective treatment coverage: critical bottlenecks in quality- and user-adjusted coverage for major depressive disorder. Psychol Med, 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Villatoro AP, Mays VM, Ponce NA, Aneshensel CS, 2018. Perceived Need for Mental Health Care: The Intersection of Race, Ethnicity, Gender, and Socioeconomic Status. Soc Ment Health 8, 1–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, Bruffaerts R, de Girolamo G, de Graaf R, Gureje O, Haro JM, Karam EG, Kessler RC, Kovess V, Lane MC, Lee S, Levinson D, Ono Y, Petukhova M, Posada-Villa J, Seedat S, Wells JE, 2007a. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. The Lancet 370, 841–850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wang PS, Angermeyer M, Borges G, Bruffaerts R, Tat Chiu W, De Girolamo G, Fayyad J, Gureje O, Haro JM, Huang Y, Kessler RC, Kovess V, Levinson D, Nakane Y, Oakley Brown MA, Ormel JH, Posada-Villa J, Aguilar-Gaxiola S, Alonso J, Lee S, Heeringa S, Pennell B-E, Chatterji S, Ustün TB, 2007b. Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization’s World Mental Health Survey Initiative. World psychiatry : official journal of the World Psychiatric Association (WPA) 6, 177–185. [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement

RESOURCES